Proteoglycan splice variants as therapeutics and diagnostics for amyloid diseases
US8956818B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 2010 |
| Grant date | Feb 17, 2015 |
| Priority date | — |
| Expiry date | Aug 10, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The identification of novel Syndecan-2 splice variants and their use in the diagnosis and therapeutic intervention of Alzheimer's disease and other amyloid diseases. In addition the use of new animal models expressing or devoid of syndecan-2 splice variants to effectively screen and identify potential therapeutic compounds for Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.